Publication: Assessing quality of life for multidrug-resistant and extensively drug-resistant tuberculosis patients
Issued Date
2019-06-01
Resource Type
ISSN
00309982
Other identifier(s)
2-s2.0-85070995822
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
JPMA. The Journal of the Pakistan Medical Association. Vol.69 2), No.6 (2019), S137-S157
Suggested Citation
Nam Xuan Vo, Thy Bui Xuan Doan, Di Ngoc Kha Vo, Tu Kim Tran, Trung Quang Vo Assessing quality of life for multidrug-resistant and extensively drug-resistant tuberculosis patients. JPMA. The Journal of the Pakistan Medical Association. Vol.69 2), No.6 (2019), S137-S157. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51614
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Assessing quality of life for multidrug-resistant and extensively drug-resistant tuberculosis patients
Other Contributor(s)
Abstract
Objective: One can hypothesize that Mycobacterium genus originated more than 150 million years ago and has evolved to become one of the leading lethal infectious diseases. Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) patients are directly affected by the disease and other subjective issues, such as related diseases, medical costs and social issues, which all have negative impacts on patient quality of life (QOL). Our purpose is to define the status of health-related QOL for international MDR-TB and XDR-TB patients. Methods: Systematic review is a good method for searching and selecting related researches and articles. As such, we have searched for and cited related articles on reputable databases, such as PubMed, Cochrance, and Google Scholar. A data overview was performed to draw conclusions and results on the QOL of MDR-TB and XDR-TB patients. Results: A total of 18 articles were included, using instruments from the World Health Organization, Euroqol, Short Form, AQ and the Seattle Obstructive Lung Disease Questionnaire. The QOL of MDR-TB and XDR-TB patients was found to be compromised due to the strong resistance of Mycobacterium tuberculosis, economic pressure and community alienation. Conclusions: A number of QOL and health-related QOL studies on MDR-TB and XDR-TB patients are limited, especially with XDR-TB patients. Significant numbers of MDR-TB and XDR-TB patients still have sequelae after completing treatment, reducing the health-related QOL among these patients.